(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

3DM 3-D MATRIX MEDICAL TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

3DM 3-D MATRIX MEDICAL TECHNOLOGY

ST13

US500000090515880

Class

5, 44

Filing

90515880

Registration

6792138

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

07/05/2023

Trademark type

Combined

Nice classes

5, 44

Filing date

02/06/2021

Registration date

07/19/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/19/2022

Last transaction

07/05/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

06/01/2020

First use in commerce

06/01/2020

Drawing code

3

Owner type

03

Owner location

CAMBRIDGE, MA

Examiner

STOIDES, KATHERINE

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design followed by the words "3-D MATRIX MEDICAL TECHNOLOGY" displayed in two rows separated by a line. The top row consists of a design composed of three abstract shapes, loosely based on the letters "3DM" followed by the words "3-D MATRIX". The abstract shapes are composed of a rounded rectangle with a wavy left edge, a semi-circle, and a rounded rectangle with a flat bottom.

Holders and representatives

Holders

3-D Matrix, Ltd.

Representatives

Constantine LINNIK IP SUPRA, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationssynthetic peptide hydrogels for medical purposes for use as an absorbable bulking agenthemostatic agentwound healing agentagent preventing adhesion and scar tissue formationfor tissue protection in generalfor use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical proceduresincluding endoscopic surgeries; medical preparations for the treatment of disorders and conditions in earnose and throat or gastrointestinal tract; medical preparations for use as an embolic agent in treatment of cancer; medical preparations for uplifting or separating tissues during surgery; syringes pre-filled with synthetic peptide hydrogel solution for medical purposes for use as an absorbable bulking agenthemostatic agentwound healing agentagent preventing adhesion and scar tissue formationfor tissue protection in generalfor use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical proceduresincluding endoscopic surgeries; excluding from any of the aforementioned a coating to provide a porous surface for bony attachment to an orthopedic implant

Class 44

Providing a website featuring health and medical information about medical productsspecifically about self-assembling peptide hydrogels and their medical applications

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/19/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/19/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/03/2022

PUBO

PUBLISHED FOR OPPOSITION

05/03/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/13/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/31/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

03/30/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/30/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

03/30/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/30/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/04/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/04/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/03/2022

ALIE

ASSIGNED TO LIE

03/02/2022

DOCK

ASSIGNED TO EXAMINER

02/07/2022

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

02/01/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

02/01/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/03/2021

GNRT

NON-FINAL ACTION E-MAILED

09/03/2021

CNRT

NON-FINAL ACTION WRITTEN

09/03/2021

DOCK

ASSIGNED TO EXAMINER

08/30/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2021

NWAP

NEW APPLICATION ENTERED

02/10/2021

Continuous trademark protection

Get notified about every new filing that threatens 3DM 3-D MATRIX MEDICAL TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.